BMP4 promotes prostate tumor growth in bone through osteogenesis.
about
A Survey of Strategies to Modulate the Bone Morphogenetic Protein Signaling Pathway: Current and Future PerspectivesMolecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancerA new class of small molecule inhibitor of BMP signalingCombined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathwaysPromoter hypomethylation of EpCAM-regulated bone morphogenetic protein gene family in recurrent endometrial cancerBone Morphogenetic Proteins stimulate mammary fibroblasts to promote mammary carcinoma cell invasionRecurrent chromosome 22 deletions in osteoblastoma affect inhibitors of the Wnt/beta-catenin signaling pathway.Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironmentBreast cancer cells promote osteoblastic differentiation via Sema 3A signaling pathway in vitro.PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.BMP4 depletion by miR-200 inhibits tumorigenesis and metastasis of lung adenocarcinoma cells.Effect of Paget's disease of bone (osteitis deformans) on the progression of prostate cancer bone metastasis.Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis.A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.Inhibition of BMP signaling suppresses metastasis in mammary cancerIntegrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer.Bone morphogenetic protein- and mating-dependent secretory cell growth and migration in the Drosophila accessory glandBiomolecular basis of the role of diabetes mellitus in osteoporosis and bone fracturesThe Drosophila Accessory Gland as a Model for Prostate Cancer and Other Pathologies.Neurosurgery concepts: Key perspectives on imaging characteristics of spinal metastases, surgery for low back pain, anesthesia for disc surgery, and laminectomy versus laminectomy and fusion for lumbar spondylolisthesis.Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling.Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of β-catenin activation of the DKK1 promoter in prostate cancer.Bi-directional roles of bone morphogenetic proteins in cancer: another molecular Jekyll and Hyde?Signaling between tumor cells and the host bone marrow microenvironment.Differences of osteoblastic bone metastases and osteolytic bone metastases in clinical features and molecular characteristics.Management of diffuse intrinsic pontine glioma in children: current and future strategies for improving prognosis.Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer.P53 deficiency-induced Smad1 upregulation suppresses tumorigenesis and causes chemoresistance in colorectal cancers.The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target.Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer.Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppression.Upregulation of bone morphogenetic protein 4 is associated with poor prognosis in patients with hepatocellular carcinoma.BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation.The Dual Role of Bone Morphogenetic Proteins in Cancer.Mean-field approach to evolving spatial networks, with an application to osteocyte network formation.Structural basis for the potent and selective binding of LDN-212854 to the BMP receptor kinase ALK2.Proteomics Profiling of Exosomes from Primary Mouse Osteoblasts under Proliferation versus Mineralization Conditions and Characterization of Their Uptake into Prostate Cancer Cells.Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer models.Differential gene expression induced by anti-cancer agent plumbagin is mediated by androgen receptor in prostate cancer cells.Opposing roles of TGFβ and BMP signaling in prostate cancer development.
P2860
Q26739015-AD5027C1-E981-498A-AA99-15F6509BF14EQ27024775-D8F63100-4EEA-4CBE-8365-A5FE8397BD52Q27678000-D09FBBAF-DD0A-4440-8699-30C91A9EB584Q28484572-22EAEF4B-A3AA-4586-99E4-8AA5750B8098Q33841409-22317748-129D-486E-8033-83CD1CCDD758Q34807620-EADE7675-C43F-4799-A503-40B061BD3BCBQ35044006-971403AD-8917-4F13-A063-7CABEBF25E7CQ35148340-D0456F48-8BBE-4B87-A64F-523C7BA2A436Q35406039-DAA5A416-DA43-45C1-8F5F-1113BBE582FCQ35845897-F43BF340-DD1D-4A49-8946-4F3E76D60AECQ36086181-9766E216-3664-4F2F-9575-DA155D6504EDQ36166840-AF2228A7-4B11-43D1-8D08-697D7C77816EQ36356105-CA6EA7D8-73E4-42B6-8635-F9F8CE158CA4Q36385066-00EE73F3-122A-4411-8940-8393CCD41A78Q36398681-88314647-DAD8-4ED8-B34B-9421C1955272Q36436763-B19BB67A-D2AA-4C79-A1A4-883F842F9F66Q36437038-AE123410-774A-405A-A7E9-8E3392DE2FABQ37101614-F06A865F-8953-4D54-B917-F43D32670C81Q37577716-DB3CF1F5-1E14-4FBA-9B77-2BC72CCCB59FQ37620985-1A65655B-DB88-4778-8F26-3B7823E66F9BQ37698312-8E0B8630-0BF2-4CFD-88CA-DCAD834DF32EQ37732437-B45860A7-762E-40C4-9788-2BE6F9157158Q38115632-DD81F6A8-5B70-42F6-87FE-C90CBF3E939BQ38138849-C34ACF1A-0C70-40EE-945D-35ABAD562D0DQ38263353-A4877042-A520-4E67-8787-3618E2F35D57Q38273428-056BB28B-C374-4EE5-8C38-B4EE4A0146B2Q38822335-8A4AF267-3FE5-47F4-807F-BD7D0463C6B0Q41253276-EC280C83-782B-48E6-A8CF-228E54D3CB78Q41462285-56529EE9-9DEB-4A61-8EBE-FBB1DBB40DA9Q41474636-193AFD06-55C6-46A5-AA36-9215A8CDBCEDQ41689907-B1510281-49C3-4C1C-B731-DB9A41B5FA6FQ43814580-E5DCB090-8805-4003-ADB4-0B9ED701B6C3Q47129742-0F0E76BB-CEEB-410F-A131-094F2F1CCA52Q47163689-FECDD81D-62FA-4DDA-86CC-74CD4EE1BA43Q47557560-9812C0B9-33FC-40FF-AF76-7EF46692738BQ47882574-83D67F4B-E6AF-4531-B8C2-EABEA166EA0BQ48179861-2A51DCE7-7EC3-428B-98B5-6F419DEC54DBQ48349923-5079A050-88AE-4BF1-83CB-2D409C852358Q49186848-D623AE81-B339-4733-8268-E086ADB93AC6Q49912287-1B4C8527-2B4F-4B21-988C-96DA8DEA6A02
P2860
BMP4 promotes prostate tumor growth in bone through osteogenesis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
BMP4 promotes prostate tumor growth in bone through osteogenesis.
@en
BMP4 promotes prostate tumor growth in bone through osteogenesis.
@nl
type
label
BMP4 promotes prostate tumor growth in bone through osteogenesis.
@en
BMP4 promotes prostate tumor growth in bone through osteogenesis.
@nl
prefLabel
BMP4 promotes prostate tumor growth in bone through osteogenesis.
@en
BMP4 promotes prostate tumor growth in bone through osteogenesis.
@nl
P2093
P2860
P1433
P1476
BMP4 promotes prostate tumor growth in bone through osteogenesis.
@en
P2093
Chien-Jui Cheng
Gary E Gallick
Jing-Fang Lu
Li-Yuan Yu-Lee
Mehmet A Bilen
Robert L Satcher
Sankar N Maity
Sue-Hwa Lin
Yu-Chen Lee
P2860
P304
P356
10.1158/0008-5472.CAN-10-4374
P407
P577
2011-06-13T00:00:00Z